Colonial Wellington Global Health & Biotech - Managed Fund

The objective of the Colonial Wellington Global Health & Biotech managed fund is The option's strategy is to add value by investing, over the medium to long term, in quality companies, with sustainable earnings per share growth and sensible valuations, whose primary business is healthcare related. The option does not hedge currency risk.

The strategy of the Colonial Wellington Global Health & Biotech managed fund is The option's strategy is to add value by investing, over the medium to long term, in quality companies, with sustainable earnings per share growth and sensible valuations, whose primary business is healthcare related. The option does not hedge currency risk.

The APIR code of the Colonial Wellington Global Health & Biotech managed fund is FSF0146AU.

Colonial Wellington Global Health & Biotech’s total return last month was -4.64%. This was made up of a growth return of -0.65% and an income return of -3.99%. These returns were calculated as at 31 Jan 2026.

Colonial Wellington Global Health & Biotech’s total return for the last three months was 1.76%. This was made up of a growth return of -7.9% and an income return of 9.66%%. These returns were calculated as at 31 Jan 2026.

Colonial Wellington Global Health & Biotech’s one-year total return is -1.22%. This was made up of a growth return of -2.12% and an income return of 0.9%. These returns were calculated as at 31 Jan 2026.

Colonial Wellington Global Health & Biotech’s one-year total return is 7.39%. This was made up of a growth return of 6.83% and an income return of 0.56%. These returns were calculated as at 31 Jan 2026.

The asset allocation of the Colonial Wellington Global Health & Biotech managed fund is :

The Responsible Entity for the Colonial Wellington Global Health & Biotech managed fund is Colonial First State Investments Limited.

The Colonial Wellington Global Health & Biotech managed fund belongs to the Equity World Other sector/asset class.

As at 31 Jan 2026, the size of the Colonial Wellington Global Health & Biotech managed fund was $11595475 million.

The Colonial Wellington Global Health & Biotech managed fund has an inception date of 14 Apr 2000.

The current entry price of the Colonial Wellington Global Health & Biotech managed fund is $5.3058 per unit and the current exit price is $5.2952 per unit (as at 11 Feb 2026).

The current exit price of the Colonial Wellington Global Health & Biotech managed fund is $5.2952 per unit and the current entry price is $5.3058 per unit (as at 11 Feb 2026).

The minimum initial investment amount for the Colonial Wellington Global Health & Biotech managed fund is $5,000. Minimum additional investment is $0.